Journal of Clinical Investigation · 2010 · 244 citations · 51 references
Life SciencesImmunologyPathologyAutoimmunityImmunopathologyInflammationCeliac DiseaseGastrointestinal ImmunologyGastrointestinal InflammationGut-associated Lymphoid TissueImmune Cell SignalingT Cell BiologyAntiapoptotic Protein SignalingCeliac Disease ImmunologyCeliac Disease PathogenesisEnteropathy-associated T-cell LymphomaIntestinal Intraepithelial LymphocytesLymphocyte Survival SignalsMucosal Intraepithelial LymphocytesRefractory Celiac Disease
Enteropathy-associated T cell lymphoma is a severe complication of celiac disease (CD). One mechanism suggested to underlie its development is chronic exposure of intraepithelial lymphocytes (IELs) to potent antiapoptotic signals initiated by IL-15, a cytokine overexpressed in the enterocytes of individuals with CD. However, the signaling pathway by which IL-15 transmits these antiapoptotic signals has not been firmly established. Here we show that the survival signals delivered by IL-15 to freshly isolated human IELs and to human IEL cell lines derived from CD patients with type II refractory CD (RCDII) - a clinicopathological entity considered an intermediary step between CD and enteropathy-associated T cell lymphoma - depend on the antiapoptotic factors Bcl-2 and/or Bcl-xL. The signals also required IL-15Rbeta, Jak3, and STAT5, but were independent of PI3K, ERK, and STAT3. Consistent with these data, IELs from patients with active CD and RCDII contained increased amounts of Bcl-xL, phospho-Jak3, and phospho-STAT5. Furthermore, incubation of patient duodenal biopsies with a fully humanized human IL-15-specific Ab effectively blocked Jak3 and STAT5 phosphorylation. In addition, treatment with this Ab induced IEL apoptosis and wiped out the massive IEL accumulation in mice overexpressing human IL-15 in their gut epithelium. Together, our results delineate the IL-15-driven survival pathway in human IELs and demonstrate that IL-15 and its downstream effectors are meaningful therapeutic targets in RCDII.
51
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Tilman Oltersdorf, Steven W. Elmore, Alexander R. Shoemaker et al. · Nature · 2005 · 3.4K citations
IL-15 Receptor Maintains Lymphoid Homeostasis by Supporting Lymphocyte Homing and Proliferation
James P. Lodolce, David L. Boone, Sophia Chai et al. · Immunity · 1998 · 1.3K citations · Full text
Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma
Christophe Cellier, Éric Delabesse, Christine Helmer et al. · The Lancet · 2000 · 753 citations